Articles on Litigation Spotlight

    Mass Tort of the Month: Toxic Baby Food Litigation

    By | on 30, Mar 2021 |   Litigation Spotlight

      The Government Report In February 2021, the U.S. House of Representatives Subcommittee on Economic and Consumer Policy, Committee on Oversight and Reform (“the Committee”) issued a report revealing [...] Read More

    Mass Tort of the Month: Elmiron

    By | on 16, Feb 2021 |   Litigation Spotlight

    On the radar as one of the mass torts slated to make significant progress in 2021, the Elmiron litigations closed out 2020 with a newly consolidated multidistrict litigation (“MDL”) and saw continued [...] Read More

    Mass Tort of the Month: Paragard®

    By | on 05, Feb 2021 |   Litigation Spotlight

    The Paragard litigations were one of a number of mass torts to make headlines in the final months of 2020. The first steps towards the formation of a multidistrict litigation (“MDL”) were taken in Sep[...] Read More

    Mass Torts to Keep an Eye on in 2021

    By | on 11, Jan 2021 |   Litigation Spotlight

    With the advent of 2021 and consistent progress reported in COVID-19 vaccine development and administration, many are looking forward to a gradual return to a pre-pandemic pace of business. This is es[...] Read More

    Top 5 Mass Torts of 2020

    By | on 15, Dec 2020 |   Litigation Spotlight

    The year 2020 was newsworthy in almost every regard and caused most Americans to drastically change the way they live and work. The legal industry saw a dramatic shift from in-person interactions, bri[...] Read More

    Mass Tort of the Month: Valsartan Litigation

    By | on 22, Oct 2020 |   Litigation Spotlight

    In recent months, media exposure surrounding Zantac litigation has spurred wide-reaching familiarity with the chemical compounds N-nitrosodimethylamine (“NDMA”) and N-Nitrosodiethylamine (“NDEA”), amo[...] Read More

    New Call-to-action